Ceribell Inc (NASDAQ: CBLL) is a medical technology company focused on transforming the diagnosis and management of neurological conditions. The company develops and commercializes medical devices and related products targeting brain monitoring, with reliance on international manufacturing and supply chain operations disclosed in its FY2025 10-K (filed 2026-02-24). Ceribell is classified as an emerging growth company under the JOBS Act, indicating an early commercial stage. The filing discloses clinical testing and research activities, intellectual property as a core asset, and dependence on third-party manufacturers and suppliers. Revenue is generated through the sale of its medical technology products, though specific revenue figures, segment breakdowns, and customer concentration data are not present in the available filing excerpts. The company operates in the medical device sector and faces regulatory requirements governing product development, clinical trials, and commercialization.

Revenue model

Product sales of medical technology devices. Specific pricing model, revenue figures, and segment breakdowns are not supported by the available filing excerpts.

Products and services

Medical technology products focused on neurological diagnosis and monitoring. Specific product names and brands are not disclosed in the available filing excerpts.

Customers and end markets

End markets include healthcare settings where neurological diagnosis and brain monitoring occur. Specific customer types, customer counts, and concentration data are not disclosed in the available filing excerpts.

Value-chain role

Medical device developer and commercial-stage manufacturer relying on third-party international component manufacturers and suppliers.

Geographic exposure

International manufacturing and supply chain operations disclosed. Domestic U.S. operations implied by SEC registration and federal government shutdown risk disclosure. Specific geographic revenue mix is not supported by the available filing excerpts.

Source: SEC 10-K, filed 2026-02-24

Industry: Electromedical & Electrotherapeutic Apparatus